Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage (NCT04688749) | Clinical Trial Compass
TerminatedNot Applicable
Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage
Stopped: Due to COVID-19
Greece50 participantsStarted 2019-07-17
Plain-language summary
The purpose of this clinical study is to evaluate if the DermaSense prototype EIS scanner can provide medical decision support which can complement dermoscopy-based identification of the disease at time of biopsy decision.
Who can participate
Age range8 Years – 90 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
The inclusion criteria for patients in this study are as follows:
* Male or female at least 8 years old
* Individuals diagnosed with confirmed skin damage by Dermatologists
* Lesions that present with unclear clinical presentation to allow for clinical diagnosis of benign or minimally dysplastic nevus (nevi), so necessitating a biopsy.
* The inclusion of patients in this study is independent from the current therapy. During the study all patients will be kept on a therapy that is medically indicated
* Participant himself or legal guardian/representative willing and consenting to participate to the study by giving written informed consent
* Participants under 18 years old must have a parent, or / and other reliable caregiver who agrees to accompany him/her to the measurements, provide information about the participant as required by the protocol
The inclusion criteria for healthy controls in this study are as follows:
* Male or female at least 8 years old
* Matched healthy control population: Individuals without skin damage (melanoma, BCC, SCC, etc) that have been included in cohort.
* Lesions that present with unclear clinical presentation to allow for clinical diagnosis of benign or minimally dysplastic nevus (nevi), so necessitating a biopsy.
* The inclusion of patients in this study is independent from the current therapy. During the study all patients will be kept on a therapy that is medically indicated
* Participant himself or legal guardian/representative willing an…